J Mellors
Overview
Explore the profile of J Mellors including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
746
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tipton T, Hall Y, Bore J, White A, Sibley L, Sarfas C, et al.
Nat Commun
. 2021 Feb;
12(1):1153.
PMID: 33608536
Zaire ebolavirus (EBOV) is a highly pathogenic filovirus which can result in Ebola virus disease (EVD); a serious medical condition that presents as flu like symptoms but then often leads...
2.
Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, McIntyre J, et al.
Proc Natl Acad Sci U S A
. 2006 Apr;
103(18):7094-9.
PMID: 16641095
Single-dose nevirapine (sdNVP) for prevention of mother-to-child transmission of HIV-1 can select nevirapine (NVP)-resistant variants, but the frequency, duration, and clinical significance of this resistance is not well defined. We...
3.
Tarwater P, Mellors J, Gore M, Margolick J, Phair J, Detels R, et al.
Am J Epidemiol
. 2001 Oct;
154(7):675-81.
PMID: 11581102
Two methods are presented for measuring population effectiveness (i.e., reduction of disease in a population in which only some receive treatment) of antiretroviral therapy among human immunodeficiency virus (HIV)-infected men...
4.
Mellors J, Kemp S
AIDS Alert
. 2001 Sep;
16(8):103-4.
PMID: 11547700
John Mellors, MD, professor of medicine and chief of infectious diseases at the University of Pittsburgh, and Sharon Kemp, director of HIV Research for Virco UK in Cambridge, United Kingdom,...
5.
6.
Huang W, de Gruttola V, Fischl M, Hammer S, Richman D, Havlir D, et al.
J Infect Dis
. 2001 Apr;
183(10):1455-65.
PMID: 11319681
Early identification of treatment failure among human immunodeficiency virus (HIV) type 1--infected patients receiving antiretroviral therapy could enable clinicians to modify inadequate regimens and to improve treatment response. Clinical definitions...
7.
Gunthard H, Havlir D, Fiscus S, Zhang Z, Eron J, Mellors J, et al.
J Infect Dis
. 2001 Apr;
183(9):1318-27.
PMID: 11294662
Residual viral replication persists in a significant proportion of human immunodeficiency virus (HIV)-infected patients receiving potent antiretroviral therapy. To determine the source of this virus, levels of HIV RNA and...
8.
Lederman M, McKinnis R, Kelleher D, Cutrell A, Mellors J, Neisler M, et al.
AIDS
. 2000 Dec;
14(17):2635-42.
PMID: 11125881
Objective: To characterize early and later indices of cellular restoration among HIV-1 infected persons treated with abacavir and one protease inhibitor and to identify predictors of CD4 cell increases. Methods:...
9.
Degruttola V, Dix L, DAquila R, Holder D, Phillips A, Ait-Khaled M, et al.
Antivir Ther
. 2000 Jun;
5(1):41-8.
PMID: 10846592
To assess the relation between resistance to antiretroviral drugs for treatment of HIV-1 infection and virological response to therapy, results from 12 different studies were re-analysed according to a standard...
10.